Pädiatrie
Placing pediatric patients and their families at the center.
From design to execution, we understand the inherent challenges of pediatric studies and will help you navigate the best path ahead.
Trusted guidance
Leverage our deep understanding of the diverse populations—spanning preterm infants to adolescents.
A patient-centric focus
Address the needs of pediatric patients and their families with our extensive regulatory, medical and operational expertise.
Efficient enrollment
Speed up your pediatric drug development plan with our best practices to efficiently enroll adolescents and young adult populations.
Minimizing patient and family burden
Participating in a pediatric trial requires a huge commitment not just from a patient, but also from their family. That's why our pediatric experts develop tailored solutions that address specific study considerations, minimize the burden of participation and support successful study conduct.
We share your passion to make a difference in patients' lives. Working with Fortrea, you'll get a partner that:
- Understands the nuances of pediatric research
- Brings long-standing experience designing, planning and conducting pediatric programs
- Delivers the collective knowledge of 34 pediatricians and more than 2.400 employees experienced with pediatric populations
Together, let’s overcome challenges and enable efficient delivery for pediatric studies.
Pediatric experience that matters
In the last 5 years, we have supported:
Our top therapeutic areas for pediatrics
Engaged team, committed to good work. We genuinely enjoy working with our Fortrea partners.
Large Pharma
Erkenntnisse
Get the latest updates from our pediatrics team
SGLT2-Inhibitoren als nierenschützende Agenten für pädiatrische Patienten mit chronischen Nierenerkrankungen
Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection.
Weiterlesen
Implementing a novel approach for recruiting a seasonal pediatric vaccine mega-trial
This case study demonstrates how Fortrea developed a novel approach to successfully delivery a large, industry-sponsored Phase III clinical trial to prevent hospitalization of infants due to a seasonal and dangerous illness.
Fallstudie herunterladen
Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Conducting pediatric trials in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Download White Paper
Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation
Learn about the experiences of the young participants involved in the clinical trials.
Weiterlesen
Tag der seltenen Krankheiten: Feier des Fortschritts und Hoffnung für die Zukunft
Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.
WeiterlesenPediatric trials are complex and require the ability to adapt
As your agile partner, we work as an extension of your team and:
- Entwicklung und Ausübung Ihrer pädiatrischen Regulierungsstrategie und effektive Beratung zur Förderung von PIP und iPSP
- Entwicklung pädiatrischer Programme und Studiendesign, einschließlich der Erstellung von Protokollen
- Ermöglichung einer maßgeschneiderten Strategie und Planung für Ihr Programm, einschließlich Machbarkeitsstudien und Auswahl des für Ihre Studie am besten geeigneten Landes und Standorts
- Create relevant patient and family-facing materials including assent/consent for the different pediatric age groups
- Collaborate with relevant advocacy groups, such as the International Children’s Advisory Network (iCAN)